Prognostic significance of FXYD-3 in Patients who underwent resection of Colorectal Liver Metastases
| Field | Value | Language |
| dc.contributor.author | Bhimani, Nazim | |
| dc.date.accessioned | 2019-05-06 | |
| dc.date.available | 2019-05-06 | |
| dc.date.issued | 2019-05-03 | |
| dc.identifier.uri | http://hdl.handle.net/2123/20359 | |
| dc.description | Workplace Project Portfolio by Nazim Bhimani. Supervisors: Associate Professor Patrick Kelly and Professor Thomas Hugh | en |
| dc.description.abstract | Background: Colorectal cancer (CRC) is the third most common cancer in Australia and approximately 50% of these patients will eventually develop colorectal liver metastases (CRLM) [1-3]. Many organs such as the breast, pancreas, lung, stomach and rectum have varying expression levels of FXYD-3. There are conflicting results from studies examining the relationship between FXYD-3 expression and CRC, and to date there have been no studies on the expression of FXYD-3 in CRLM. Aims: The aim of this study is to determine the prevalence of FXYD-3 expression in patients with primary CRC and those that develop CRLM, and determine if FXYD-3 expression is associated with survival after resection of CRLM. | en |
| dc.language.iso | en_AU | en |
| dc.rights | The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission. | en |
| dc.subject | FXYD-3 | en |
| dc.subject | colorectal cancer | en |
| dc.subject | colorectal liver metastasis, | en |
| dc.title | Prognostic significance of FXYD-3 in Patients who underwent resection of Colorectal Liver Metastases | en |
| dc.type | Article | en |
| usyd.faculty | Faculty of Medicine and Health | |
| usyd.department | Biostatistics, School of Public Health | en |
Associated file/s
Associated collections